imipramine has been researched along with oxidopamine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (52.17) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Mustafa, AA | 1 |
| Gale, K; Meloni, R | 1 |
| Nowak, G | 1 |
| Howe, BB; Keith, RA; Salama, AI | 1 |
| Antkiewicz-Michaluk, L; Marona-Lewicka, D; Michaluk, J; Rokosz-Pelc, A; Vetulani, J | 1 |
| Fukuda, S; Lee, TJ; Su, C | 1 |
| Naumenko, EV; Serova, LI | 1 |
| Aihara, H; Araki, H; Kawashima, K; Uchiyama, Y | 1 |
| Pilc, A; Vetulani, J | 1 |
| Dumbrille-Ross, A; Tang, SW | 1 |
| Duman, RS; Enna, SJ | 1 |
| Dawson, TM; Wamsley, JK | 1 |
| Petty, F; Sherman, AD | 1 |
| Furukawa, K; Ito, T; Kadokawa, T; Karasawa, T; Shimizu, M | 1 |
| Duman, RS; Hosoda, K | 1 |
| Burkhardt, K; Kaftan, A; Schwarz, J; Storch, A | 1 |
| Bourin, M; Chenu, F; Dailly, E | 1 |
| Frazer, A; Furmaga, H; Shah, A | 1 |
| Berghauzen-Maciejewska, K; Dziubina, A; Głowacka, U; Kolasiewicz, W; Kuter, K; Ossowska, K; Wardas, J | 1 |
| Andreatini, R; Bruginski, E; Campos, FR; de Almeida Soares Hocayen, P; Kanazawa, LKS; Miyoshi, E; Schwarting, RKW; Stern, CAJ; Vecchia, DD; Vital, MABF; Wendler, E; Wöhr, M | 1 |
| Andreatini, R; Da Cunha, C; Hocayen, PAS; Kanazawa, LKS; Miyoshi, E; Takahashi, RN; Vecchia, DD; Vital, MABF; Wendler, E | 1 |
23 other study(ies) available for imipramine and oxidopamine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Rapid desensitization of central beta-adrenoceptors in rat after subacute treatment with imipramine and calcium entry blockers.
Topics: 1-Propanol; Animals; Calcium Channel Blockers; Clonidine; Diltiazem; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drinking Behavior; Fenclonine; Imipramine; Isoproterenol; Ketanserin; Nicardipine; Nifedipine; Oxidopamine; Rats; Receptors, Adrenergic, beta; Verapamil | 1991 |
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigra.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Diseases; Brain Tissue Transplantation; Cocaine; Dopamine; Fetal Tissue Transplantation; Fluoxetine; Imipramine; Male; Neural Pathways; Neurotransmitter Uptake Inhibitors; Nomifensine; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Substantia Nigra | 1991 |
Long-term effect of antidepressant drugs and electroconvulsive shock (ECS) on cortical alpha 1-adrenoceptors following destruction of dopaminergic nerve terminals.
Topics: Animals; Antidepressive Agents; Cerebral Cortex; Citalopram; Dopamine; Electroshock; Hydroxydopamines; Imipramine; Male; Nerve Endings; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin | 1989 |
Modulation of peripheral beta-1 and alpha-2 receptor sensitivities by the administration of the tricyclic antidepressant, imipramine, alone and in combination with alpha-2 antagonists to rats.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Dioxanes; Heart Rate; Hydroxydopamines; Idazoxan; Imipramine; In Vitro Techniques; Isoproterenol; Male; Oxidopamine; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1986 |
The effect of chronic imipramine and electroconvulsive shock treatment on [3H]DADLE binding to cortical membranes of rats pretreated with chronic reserpine or 6-hydroxydopamine.
Topics: Animals; Cell Membrane; Cerebral Cortex; Electroshock; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Hydroxydopamines; Imipramine; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Reserpine | 1987 |
Mechanisms of extraneuronal serotonin uptake in the rat aorta.
Topics: Animals; Aorta; Cocaine; Cold Temperature; Corticosterone; Desipramine; Hydroxydopamines; Imipramine; Kinetics; Male; Neurons; Norepinephrine; Oxidopamine; Pargyline; Rats; Rats, Inbred Strains; Serotonin | 1986 |
[Zoosocial behavior and the endocrine function of the gonads of male mice after destruction of the endings of the noradrenergic neurons in the brain].
Topics: Animals; Brain; Brain Chemistry; Hierarchy, Social; Hydroxydopamines; Imipramine; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Nerve Endings; Neurons; Nomifensine; Norepinephrine; Oxidopamine; Social Behavior; Testis; Testosterone | 1987 |
Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim.
Topics: 5,7-Dihydroxytryptamine; Amygdala; Animals; Biogenic Amines; Brain Chemistry; Catecholamines; Desipramine; Hydroxydopamines; Imipramine; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Swimming | 1985 |
Attenuation by chronic imipramine treatment of [3H]clonidine binding to cortical membranes and of clonidine-induced hypothermia: the influence of central chemosympathectomy.
Topics: Animals; Body Temperature Regulation; Cerebral Cortex; Clonidine; Hydroxydopamines; Imipramine; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic | 1982 |
Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities.
Topics: Animals; Dihydroalprenolol; Hydroxydopamines; Imipramine; Male; Norepinephrine; Oxidopamine; Raphe Nuclei; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin; Spiperone; Tritium | 1983 |
beta-Adrenergic receptor regulation and antidepressants: the influence of adrenocorticotropin.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Cerebral Cortex; Cyclic AMP; Desipramine; Dihydroalprenolol; Hydroxydopamines; Imipramine; Male; Mianserin; Oxidopamine; Pargyline; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1983 |
Autoradiographic localization of [3H]-imipramine binding sites: association with serotonergic neurons.
Topics: 5,7-Dihydroxytryptamine; Animals; Autoradiography; Binding Sites; Brain; Catecholamines; Hydroxydopamines; Imipramine; Male; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin | 1983 |
A pharmacologically pertinent animal model of mania.
Topics: Affective Disorders, Psychotic; Animals; Bipolar Disorder; Disease Models, Animal; Electroshock; Humans; Hydroxydopamines; Imipramine; Injections, Intraventricular; Lactates; Lactic Acid; Lithium; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains | 1981 |
Effects of chlorpromazine, imipramine and baclofen on the spinal polysynaptic reflex in acute, chronic and 6-hydroxydopamine-treated spinal rats.
Topics: Animals; Baclofen; Blood Pressure; Chlorpromazine; Electromyography; Hydroxydopamines; Imipramine; Male; Oxidopamine; Rats; Rats, Inbred Strains; Reflex; Spinal Cord; Synapses | 1982 |
Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex.
Topics: Animals; Electroshock; Frontal Lobe; Gene Expression Regulation; Imipramine; Male; Nucleic Acid Hybridization; Oxidopamine; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Ribonucleases; RNA Probes; RNA, Messenger | 1993 |
6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism.
Topics: 1-Methyl-4-phenylpyridinium; Adrenergic Uptake Inhibitors; Antioxidants; Catecholamines; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Energy Metabolism; Glucose; Herbicides; Humans; Imipramine; Mitochondria; Neuroblastoma; Neurons; Oxidopamine; Sympatholytics; Tumor Cells, Cultured; Vitamin E | 2000 |
Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biogenic Monoamines; Cerebral Cortex; Citalopram; Depression; Desipramine; Dopamine Uptake Inhibitors; Hippocampus; Hypothalamus; Imipramine; Injections, Intraventricular; Male; Mice; Neostriatum; Oxidopamine; Paroxetine; Swimming | 2007 |
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Anxiety; Autoradiography; Brain; Desipramine; Disease Models, Animal; Drug Delivery Systems; Exploratory Behavior; Feeding Behavior; Imipramine; Immobility Response, Tonic; Male; Neural Pathways; Norepinephrine; Oxidopamine; Protein Binding; Rats; Rats, Sprague-Dawley; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Sertraline; Swimming; Time Factors; Tritium; Vagus Nerve Stimulation | 2011 |
Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.
Topics: Animals; Antidepressive Agents; Benzothiazoles; Depression; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Imipramine; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Swimming; Treatment Outcome | 2014 |
Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: Therapeutic implications for Parkinson's disease.
Topics: Anhedonia; Animals; Depression; Disease Models, Animal; Gait; Imipramine; Ketamine; Male; Nerve Degeneration; Oxidopamine; Parkinson Disease; Pars Compacta; Rats; Rats, Wistar; Substantia Nigra; Vocalization, Animal | 2018 |
Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Imipramine; Ketamine; Male; Memory, Short-Term; Oxidopamine; Parkinson Disease; Pars Compacta; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2021 |